Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Archives of Biochemistry and Biophysics|December 27, 2011
p53 mutants induce transcription of NF-κB2 in H1299 cells through CBP and STAT binding on the NF-κB2 promoter and gain of function activityCatherine A Vaughan, Shilpa Singh, Brad Windle, et al.
Bioorganic & Medicinal Chemistry|December 18, 2007
Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activityAshutosh Tripathi, Micaela Fornabaio, Glen E Kellogg, et al.
ACS Pharmacology & Translational Science|May 16, 2024
Liposomes-Encapsulating Double-Stranded Nucleic Acid (Poly I:C) for Head and Neck Cancer TreatmentVidit Singh, Anna Chernatynskaya, Lin Qi, et al.
Genes & Cancer|June 16, 2012
Human Oncoprotein MDM2 Up-regulates Expression of NF-κB2 Precursor p100 Conferring a Survival Advantage to Lung CellsCatherine Vaughan, Lathika Mohanraj, Shilpa Singh, et al.
Oncotarget|May 12, 2016
DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the Noxa/MCL-1/CDK2 complexWataru Nakajima, Kanika Sharma, June Young Lee, et al.
Molecular Pharmacology|February 11, 2015
Yet another function of p53--the switch that determines whether radiation-induced autophagy will be cytoprotective or nonprotective: implications for autophagy inhibition as a therapeutic strategyShweta Chakradeo, Khushboo Sharma, Aisha Alhaddad, et al.
Carcinogenesis|November 25, 2011
Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migrationW Andrew Yeudall, Catherine A Vaughan, Hiroshi Miyazaki, et al.
Nature Communications|January 30, 2021
The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3Catherine A Vaughan, Shilpa Singh, Mark A Subler, et al.
Cannabis and Cannabinoid Research|December 17, 2021
Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor MicroenvironmentHesam Khodadadi, Évila Lopes Salles, Ahmet Alptekin, et al.
Human Cell|February 3, 2023
Inhalant cannabidiol impedes tumor growth through decreased tumor stemness and impaired angiogenic switch in NCI-H1437-induced human lung cancer modelÉvila Lopes Salles, Sahar Emami Naeini, Hesam Khodadadi, et al.
Pageof 6